Dachshund CLN2 Disease: Gene Therapy, TPP1 & Dogs That Save Lives | Vet Candy

What is CLN2 disease in Dachshunds, and how has canine research helped advance treatments for a devastating neurodegenerative disease? In this episode of Catching Up, Dr. Shannon Gregoire and Dr. Elan Armstrong cover remarkable stories of dogs saving human lives before diving into the science of neuronal ceroid lipofuscinosis (NCL) in Dachshunds. CLN2 disease is an inherited neurological disorder caused by mutations in the TPP1 gene, resulting in deficiency of the TPP1 enzyme and progressive neurodegeneration. Dachshunds with naturally occurring CLN2 disease have become an important research model for understanding the condition and studying potential treatments. In this episode, you'll learn: • What neuronal ceroid lipofuscinosis (NCL/CLN2) is • How TPP1 deficiency causes progressive neurological disease • Clinical signs associated with CLN2 disease in Dachshunds • How CLN2 relates to other lysosomal storage diseases • How enzyme replacement therapy has been studied • What researchers have learned from experimental gene therapy • How canine research has contributed to advances in human medicine • Incredible stories of dogs who have saved human lives From real-life rescues to groundbreaking neurological research, this episode shows just how extraordinary dogs can be. About Vet Candy Vet Candy brings veterinary professionals the latest in veterinary medicine, animal health research, clinical breakthroughs, genetics, and veterinary news. 🌐 More from Vet Candy: https://www.myvetcandy.com ✅ Join Vet Candy for free: https://www.myvetcandy.com/join 🔥 Instagram:   / myvetcandy   🔥 Facebook:   / myvetcandy   LIKE. SHARE. SUBSCRIBE. Thanks for watching Dachshund CLN2 Disease: Gene Therapy, TPP1 & Dogs That Save Lives | Vet Candy. #VeterinaryMedicine #Dachshund #GeneTherapy